Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

BACKGROUND: Cancer-related disturbances in myeloid lineage development, marked by high levels of myeloid-derived suppressor cells (MDSC) and impaired dendritic cell (DC) development, are associated with poor clinical outcome due to immune escape and therapy resistance. Redressing this balance may th...

Descripción completa

Detalles Bibliográficos
Autores principales: Santegoets, Saskia JAM, Stam, Anita GM, Lougheed, Sinéad M, Gall, Helen, Jooss, Karin, Sacks, Natalie, Hege, Kristen, Lowy, Israel, Scheper, Rik J, Gerritsen, Winald R, van den Eertwegh, Alfons JM, de Gruijl, Tanja D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507359/
https://www.ncbi.nlm.nih.gov/pubmed/26196012
http://dx.doi.org/10.1186/s40425-014-0031-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507359/
https://www.ncbi.nlm.nih.gov/pubmed/26196012
http://dx.doi.org/10.1186/s40425-014-0031-3

Ejemplares similares